Since 2010, DNA nanotechnology has advanced rapidly, helping overcome limitations in the use of DNA solely as genetic material. DNA nanotechnology has thus helped develop a new method for the construction of biosensors. Among bioprobe materials for biosensors, nucleic acids have shown several advantages. First, it has a complementary sequence for hybridizing the target gene. Second, DNA has various functionalities, such as DNAzymes, DNA junctions or aptamers, because of its unique folded structures with specific sequences. Third, functional groups, such as thiols, amines, or other fluorophores, can easily be introduced into DNA at the 5′ or 3′ end. Finally, DNA can easily be tailored by making junctions or origami structures; these unique structures extend the DNA arm and create a multi-functional bioprobe. Meanwhile, nanomaterials have also been used to advance plasmonic biosensor technologies. Nanomaterials provide various biosensing platforms with high sensitivity and selectivity. Several plasmonic biosensor types have been fabricated, such as surface plasmons, and Raman-based or metal-enhanced biosensors. Introducing DNA nanotechnology to plasmonic biosensors has brought in sight new horizons in the fields of biosensors and nanobiotechnology. This review discusses the recent progress of DNA nanotechnology-based plasmonic biosensors.

Microcystin-LR (MC-LR) is a hepatotoxin generated by excessive proliferation of cyanobacteria, which is a threat to humans and wildlife. Therefore, the rapid detection of MC-LR is an important challenge. This...

No abstract

No abstract

Cylindrospermopsin (CYN) is a freshwater algal toxin produced during the proliferation of harmful cyanobacteria, known as cyanobacterial algal blooms (cyano-HABs). Recently, the effects of global warming have facilitated the growth of cyano-HABs, leading to their worldwide occurrence and an increase in toxin-related damage to aquatic ecosystems. CYN is known to exhibit strong cell toxicity upon ingestion, inhibiting protein synthesis and glutathione production and, ultimately, leading to cell death. In addition to cell toxicity, CYN exhibits skin toxicity, genotoxicity, and hepatotoxicity. It can also affect other organs, such as the kidneys (causing tubular necrosis), thymus (causing atrophy), and heart (causing pericardial and myocardial hemorrhage). The standard method used for CYN detection to date, enzyme-linked immunosorbent assay (ELISA), has several drawbacks: it is complex, time-consuming, and requires trained researchers. Recently, biosensors have been shown to offer numerous advantages, such as their simplicity, portability, and rapidity, making them suitable for onsite applications. Consequently, recent studies have actively explored the latest biosensor-based technologies for CYN detection. This review discusses the recent advances in CYN detection platforms that utilize several types of biosensors.